TNFAIP3 and metabolic dysfunction-associated steatotic liver disease: This may be the case in patients bearing specific mutations or polymorphisms in the A20 locus, making them vulnerable to develop chronic liver diseases such as alcoholic liver disease, NAFLD and viral hepatitis, conditions known to promote the development of cirrhosis and HCC.